Pellets presentation
VRNDA PHARMA PVT LTD
Our innovative drug delivery technologies enable design of novel dosage forms that contain more than one active each with tailored drug release characteristics, and are more patient-friendly e.g. taste masked ODT of therapeutic agents for immediate or modified-release. This enables effective life cycle management and the enhancement of product life.
Our technology strengths cover the following drug delivery platforms :
- Controlled drug delivery (tablets, multi-particulates and capsules).
- MUPS technology for modified drug delivery.
- Multilayer tablet technology.
- Taste masked Orodispersible tablets (for immediate or modified drug delivery).
- Gastroretentive drug delivery.
- Enhanced bioavailability (tablets, multiparticulates, ODTs).
- Specialized technologies involved in developing and manufacturing poorly/ slowly soluble drug formulations include - Solid dispersions, Nanoparticles.
Note: SR- Sustained-release; IR-Immediate-release; DR-Delayed-release (Enteric-coat); MUPS- Multiple-unit pellet system (Tablet); GRDDS- Gastroretentive drug delivery system; TM- taste masked; Y- Yes/ Developed .
I. CARDIOVASCULAR
| Sr. No | Name of the Active principle | Pellets/ Capsules | Tablets | Others | Remark |
|---|---|---|---|---|---|
| 1 | Diltiazem HCl 90/120 & 180 mg | Y | Y | SR | |
| 2 | Metoprolol Succinate 25/ 50/ 100/ 200 mg | Y | Y | MUPS | SR |
| 3 | Isosorbride 5 mononitrate 25/30/50/60 & 120 mg | Y | Y | SR | |
| 4 | Metoprolol 25/50 SR + ISMN 30/60 | Y | Y | SR | |
| 5 | Trimetazidine 60 mg | Y | SR | ||
| 6 | Metoprolol 50 mg SR + Amlodipine 5mg | Y | Y | SR + IR | |
| 7 | Metoprolol 50 mg SR + Amlodipine 5mg | Y | Y | SR + IR | |
| 8 | Ramipril 2.5/5mg + Indapamide 1.5mg | Y | SR + IR | ||
| 9 | Metoprolol SR 50mg SR + Amlodipine 5mg | Y | Y | SR + IR | |
| 10 | Fenofibrate 145 mg | Y | IR Tablet | ||
| 11 | Aspirin 75mg + ISMN 30/60 | Y | DR + SR | ||
| 12 | Telmisartan + Hydrochlorothiazide | Y | IR + IR |
II. CENTRAL NERVOUS SYSTEM
| Sr. No | Name of the Active principle | Pellets/ Capsules | Tablets | Others | Remark | 13 | Duloxetine Capsule | Y | DR | 14 | Gabapentin 600 mg | Y | GRDDS | SR |
|---|---|---|---|---|---|
| 15 | Gabapentin 600 mg GR + Methylcobalamin 1500 mcg | Y | SR+IR | ||
| 16 | Oxcarbazepine 150 / 300 / 600 mg tablet | Y | SR | ||
| 17 | Paroxetine 12.5 / 25 / 37.5 mg SR Tablet | Y | SR | 18 | Venlafaxine HCL 37.5/75/150 mg | Y | SR |
III. DIABETES
| Sr. No | Name of the Active principle | Pellets/ Capsules | Tablets | Others | Remark |
|---|---|---|---|---|---|
| 19 | Metformin 500/1000 | Y | SR | ||
| 20 | Metformin 500/1000 mg + Gliclazide 30/60 mg | Y | SR + SR | ||
| 21 | Metformin 500/1000 mg + Glimepiride ½ mg | Y | SR + IR | ||
| 22 | Metformin 500 mg+Glibenclamide 2.5/5 mg | TM | |||
| 23 | Metformin 500 mg + Gliclazide 30/60 mg + Pioglitazone 15mg | SR+SR+IR |
IV. GASTROINTESTINAL
| Sr. No | Name of the Active principle | Pellets/ Capsules | Tablets | Others | Remark |
|---|---|---|---|---|---|
| 24 | Aprepitant 80mg | Y | IR | ||
| 25 | Domperidone 30mg | Y | SR | ||
| 26 | Mosapride 15mg | Y | SR | ||
| 27 | Esomeprazole 40mg EC + Itopride 150mg | Y | DR+SR | ||
| 28 | Esomeprazole 20/40mg EC + Domperidone 30mg | Y | |||
| 29 | Esomeprazole 20/40mg | Y | Y | MUPS | Buffered Tablet |
| 30 | Lansoprazole 15/30mg | Y | Y | MUPS | Buffered Tablet |
| 31 | Omeprazole 10/20/40mg | Y | Y | MUPS | Buffered Tablet |
| 32 | Pantoprazole 20/40mg | Y | Y | MUPS | Buffered Tablet |
| 33 | Rabeprazole 20mg | Y | Y | MUPS | Buffered Tablet |
V. INFECTION
| Sr. No | Name of the Active principle | Pellets/ Capsules | Tablets | Others | Remark | 34 | Azithromycin 250/500mg + Ambroxol 75mg | Y |
|---|---|---|---|---|---|
| 35 | Ciprofloxacin 500/1000mg | Y | SR tablet | ||
| 36 | Doxycycline hyclate 100/200 | Y | DR | ||
| 37 | Gatifloxacin 400mg + Ambroxol 75mg | Y | SR | ||
| 38 | Gemifloxacin 320mg + Ambroxol 75mg | Y | SR | ||
| 39 | Levofloxacin 500mg + Ambroxol 75mg | Y | SR | ||
| 40 | Azithromycin 2gm granules for suspension | TM | SR | ||
| 41 | Itraconazole | Y | IR | ||
| 42 | Azithromycin 100 mg/ml | TM | Suspension | ||
| 43 | Ciprofloxacin | TM | Suspension | ||
| 44 | Clarithromycin 125/250mg | TM | Suspension | ||
| 45 | Cefuroxime Axetil | TM | Suspension | ||
| 46 | Cefpodoxime | TM | Suspension |
VI. MUSCULOSKELETAL
| Sr. No | Name of the Active principle | Pellets/ Capsules | Tablets | Others | Remark |
|---|---|---|---|---|---|
| 47 | Aceclofenac 200 mg | Y | SR | ||
| 48 | Diclofenac 75/100/150 mg | Y | SR | ||
| 49 | Ketoprofen 200 mg | Y | SR | ||
| 50 | Thiocolchicoside | Y | SR |
VII. RESPIRATORY
| Sr. No | Name of the Active principle | Pellets/ Capsules | Tablets | Others | Remark |
|---|---|---|---|---|---|
| 51 | Salbutamol Sulfate 4/8 mg | Y | SR | ||
| 52 | Levocetirizine 5 mg | Y | SR | ||
| 53 | Chlorpheniramine Maleate 4/8mg | Y | SR | ||
| 54 | Ambroxol 75/120 mg | Y | SR |
VIII. UROGENITAL
| Sr. No | Name of the Active principle | Pellets/ Capsules | Tablets | Others | Remark |
|---|---|---|---|---|---|
| 55 | Tamsulosin 0.2/0.4 mg | Y | SR | ||
| 56 | Tolterodine 2/4 mg | Y | SR |
IX. ORODISPERSIBLE tablet( TASTE MASKED)
| Sr. No | Name of the Active principle | Pellets/ Capsules | Tablets | Others | Remark |
|---|---|---|---|---|---|
| 57 | Aceclofenac 100 mg | Y | |||
| 58 | Azithromycin 100/200 mg | Y | |||
| 59 | Cetirizine 10 mg | Y | |||
| 60 | Domperidone 10 mg | Y | |||
| 61 | Levocetirizine 5 mg | Y | |||
| 62 | Loratidine 10 mg | Y | |||
| 63 | Ondansetron 4/8 mg | Y | |||
| 64 | Sildenafil 25/50/100 mg | Y |
X. OBESITY/LIPID LOWERING
| Sr. No | Name of the Active principle | Pellets/ Capsules | Tablets | Others | Remark |
|---|---|---|---|---|---|
| 65 | Orlistat 120 mg | Y | IR | ||
| 66 | Capsaicin 2 mg | Y | MUPS | DR |
XI. IMMUNOSUPPRESENT
| Sr. No | Name of the Active principle | Pellets/ Capsules | Tablets | Others | Remark |
|---|---|---|---|---|---|
| 67 | Tacrolimus 0.5/1.0/5 mg | Y | IR | ||
| 68 | Sirolimus 1/5 mg | Y | IR |
GENERICS (ANDA) FOR USA and EU
| Sr. No | Name of the Active principle | Pellets/ Capsules | Tablets | Others | Remark |
|---|---|---|---|---|---|
| 69 | Metformin HCL ER Tablets | ||||
| 70 | Duloxetine ER Capsules | ||||
| 71 | Paliperidone ER Tablets | ||||
| 72 | Tolteridone Tartrate ER Capsules | ||||
| 73 | Venlafaxine HCL ER Capsules | ||||
| 74 | Darifenacin ER Tablets | ||||
| 75 | Metoprolol Succinate ER Tablets |